ArticleCell death & disease2024

Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.

Mingzhi Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.